Evidence map›Paper›PMID 29152303›Full record

ArticleJournal of therapeutic ultrasound2017

Multiple ultrasound cavitation-enabled treatments for myocardial reduction.

Douglas L Miller, Xiaofang Lu, Chunyan Dou, Yiying I Zhu, Mario L Fabiilli, Gabe E Owens, Oliver D Kripfgans

Open access · hybridAbstract read
In one paragraph

Article in Journal of therapeutic ultrasound, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.4field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 4 citations in OpenAlex.

  1. Overview of Therapeutic Ultrasound Applications and Safety Considerations: 2024 Update.Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine · 2025
    Review
  2. Article
  3. Leveraging the Imaging Transmit Pulse to Manipulate Phase-Change Nanodroplets for Contrast-Enhanced Ultrasound.IEEE transactions on ultrasonics, ferroelectrics, and frequency control · 2019
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Douglas L MillerDepartment of Radiology, University of Michigan School of Medicine, Ann Arbor, MI 48109 USA.
Xiaofang LuDepartment of Radiology, University of Michigan School of Medicine, Ann Arbor, MI 48109 USA.
Chunyan DouDepartment of Radiology, University of Michigan School of Medicine, Ann Arbor, MI 48109 USA.
Yiying I ZhuDepartment of Radiology, University of Michigan School of Medicine, Ann Arbor, MI 48109 USA.
Mario L FabiilliDepartment of Radiology, University of Michigan School of Medicine, Ann Arbor, MI 48109 USA.
Gabe E OwensDepartment of Pediatrics (Cardiology), University of Michigan School of Medicine, Ann Arbor, MI 48109 USA.
Oliver D KripfgansDepartment of Radiology, University of Michigan School of Medicine, Ann Arbor, MI 48109 USA.
University of Michigan–Ann Arbor · USMichigan Medicine · US

Funding

Therapeutic Microlesioning by Contrast Echocardiography for Myocardial ReductionR01HL114595 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI KRIPFGANS, OLIVER D · 2012 to 2016
$1.9M
NHLBI NIH HHS R01 HL114595
6 · The paper itself

Abstract

backgroundUltrasound myocardial cavitation enabled treatment (MCET) is an image-guided method for tissue reduction. In this study, a strategy of fractionated (multiple) treatments was tested for efficacy.

methodsDahl SS rats were anesthetized and prepared for treatment with a focused ultrasound transducer in a warm water bath. Aiming at the anterior left ventricular wall was facilitated by imaging with a 10 MHz phased array (10S, GE Vivid 7, GE Vingmed Ultrasound, Horten, Norway). MCET was accomplished at 1.5 MHz by pulse bursts of 4 MPa peak rarefactional pressure amplitude, which were intermittently triggered 1:8 from the ECG during infusion of a microbubble suspension for cavitation nucleation. Test groups were sham, a 200 s treatment, three 200 s treatments a week apart, and a 600 s treatment. Treatment outcome was observed by plasma troponin after 4 h, echocardiographic monitoring and histology at 6 wk.

resultsThe impacts of the fractionated treatments summed to approximately the same as the long treatment; e. g. the troponin result was 10.5 ± 3.2 for 200 s, 22.7 ± 5.4 (

conclusionThe ability to fractionate treatment may be advantageous for optimizing patient outcome relative to all-or nothing therapy by surgical myectomy or alcohol ablation.

Indexed as

ArrhythmiaCardiac myocyte necrosisHypertrophic cardiomyopathyMyocardial contrast echocardiography

Identifiers

PMID29152303
PMCPMC5679495
OpenAlexW2766212171

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.